Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic Evidence.

Zuccoli GS, Saia-Cereda VM, Nascimento JM, Martins-de-Souza D.

Front Neurosci. 2017 Sep 7;11:493. doi: 10.3389/fnins.2017.00493. eCollection 2017. Review.

2.

Serum phosphatidylinositol as a biomarker for bipolar disorder liability.

Knowles EE, Meikle PJ, Huynh K, Göring HH, Olvera RL, Mathias SR, Duggirala R, Almasy L, Blangero J, Curran JE, Glahn DC.

Bipolar Disord. 2017 Mar;19(2):107-115. doi: 10.1111/bdi.12468. Epub 2017 Feb 23.

3.

Supplementation with Omega-3 Fatty Acids in Psychiatric Disorders: A Review of Literature Data.

Bozzatello P, Brignolo E, De Grandi E, Bellino S.

J Clin Med. 2016 Jul 27;5(8). pii: E67. doi: 10.3390/jcm5080067. Review.

4.

Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?

Knöchel C, Voss M, Grüter F, Alves GS, Matura S, Sepanski B, Stäblein M, Wenzler S, Prvulovic D, Carvalho AF, Oertel-Knöchel V.

Curr Neuropharmacol. 2015;13(5):663-80. Review.

5.

Combined application of eicosapentaenoic acid and docosahexaenoic acid on depression in women: a meta-analysis of double-blind randomized controlled trials.

Yang JR, Han D, Qiao ZX, Tian X, Qi D, Qiu XH.

Neuropsychiatr Dis Treat. 2015 Aug 10;11:2055-61. doi: 10.2147/NDT.S86581. eCollection 2015.

6.

Associations of the Ratios of n-3 to n-6 Dietary Fatty Acids With Longitudinal Changes in Depressive Symptoms Among US Women.

Beydoun MA, Fanelli Kuczmarski MT, Beydoun HA, Rostant OS, Evans MK, Zonderman AB.

Am J Epidemiol. 2015 May 1;181(9):691-705. doi: 10.1093/aje/kwu334. Epub 2015 Apr 7.

7.

Metabolic syndrome and childhood trauma: Also comorbidity and complication in mood disorder.

Kesebir S.

World J Clin Cases. 2014 Aug 16;2(8):332-7. doi: 10.12998/wjcc.v2.i8.332. Review.

8.

The potential biomarker panels for identification of Major Depressive Disorder (MDD) patients with and without early life stress (ELS) by metabonomic analysis.

Ding X, Yang S, Li W, Liu Y, Li Z, Zhang Y, Li L, Liu S.

PLoS One. 2014 May 28;9(5):e97479. doi: 10.1371/journal.pone.0097479. eCollection 2014.

9.

A pilot study of plasma metabolomic patterns from patients treated with ketamine for bipolar depression: evidence for a response-related difference in mitochondrial networks.

Villaseñor A, Ramamoorthy A, Silva dos Santos M, Lorenzo MP, Laje G, Zarate C Jr, Barbas C, Wainer IW.

Br J Pharmacol. 2014 Apr;171(8):2230-42. doi: 10.1111/bph.12494.

10.

ω-3 fatty acid intakes are inversely related to elevated depressive symptoms among United States women.

Beydoun MA, Fanelli Kuczmarski MT, Beydoun HA, Hibbeln JR, Evans MK, Zonderman AB.

J Nutr. 2013 Nov;143(11):1743-52. doi: 10.3945/jn.113.179119. Epub 2013 Sep 4.

11.

A comparative genomic study in schizophrenic and in bipolar disorder patients, based on microarray expression profiling meta-analysis.

Logotheti M, Papadodima O, Venizelos N, Chatziioannou A, Kolisis F.

ScientificWorldJournal. 2013;2013:685917. doi: 10.1155/2013/685917. Epub 2013 Mar 10.

12.

Effects of dietary ratio of n-6 to n-3 polyunsaturated fatty acids on immunoglobulins, cytokines, fatty acid composition, and performance of lactating sows and suckling piglets.

Yao W, Li J, Wang JJ, Zhou W, Wang Q, Zhu R, Wang F, Thacker P.

J Anim Sci Biotechnol. 2012 Dec 27;3(1):43. doi: 10.1186/2049-1891-3-43.

13.

Metabolic syndrome in bipolar disorders.

Grover S, Malhotra N, Chakrabarti S, Kulhara P.

Indian J Psychol Med. 2012 Apr;34(2):110-8. doi: 10.4103/0253-7176.101767.

14.

Clinical trial: marine lipid suppositories as laxatives.

Ormarsson OT, Geirsson T, Bjornsson ES, Jonsson T, Moller P, Loftsson T, Stefansson E.

Mar Drugs. 2012 Sep;10(9):2047-54. doi: 10.3390/md10092047. Epub 2012 Sep 20.

15.

Oiling the brain: a review of randomized controlled trials of omega-3 fatty acids in psychopathology across the lifespan.

Sinn N, Milte C, Howe PR.

Nutrients. 2010 Feb;2(2):128-70. doi: 10.3390/nu2020128. Epub 2010 Feb 9. Review.

16.

Polyunsaturated fatty acids in various macroalgal species from North Atlantic and tropical seas.

van Ginneken VJ, Helsper JP, de Visser W, van Keulen H, Brandenburg WA.

Lipids Health Dis. 2011 Jun 22;10:104. doi: 10.1186/1476-511X-10-104.

17.

Leukocyte telomere length in major depression: correlations with chronicity, inflammation and oxidative stress--preliminary findings.

Wolkowitz OM, Mellon SH, Epel ES, Lin J, Dhabhar FS, Su Y, Reus VI, Rosser R, Burke HM, Kupferman E, Compagnone M, Nelson JC, Blackburn EH.

PLoS One. 2011 Mar 23;6(3):e17837. doi: 10.1371/journal.pone.0017837.

18.

Fourth revolution in psychiatry - Addressing comorbidity with chronic physical disorders.

Gautam S.

Indian J Psychiatry. 2010 Jul;52(3):213-9. doi: 10.4103/0019-5545.70973.

19.

Effect of omega-3 fatty acids on heart rate variability in depressed patients with coronary heart disease.

Carney RM, Freedland KE, Stein PK, Steinmeyer BC, Harris WS, Rubin EH, Krone RJ, Rich MW.

Psychosom Med. 2010 Oct;72(8):748-54. doi: 10.1097/PSY.0b013e3181eff148. Epub 2010 Aug 17.

20.

Docosahexaenoic acid suppresses neuroinflammatory responses and induces heme oxygenase-1 expression in BV-2 microglia: implications of antidepressant effects for ω-3 fatty acids.

Lu DY, Tsao YY, Leung YM, Su KP.

Neuropsychopharmacology. 2010 Oct;35(11):2238-48. doi: 10.1038/npp.2010.98. Epub 2010 Jul 28.

Supplemental Content

Support Center